Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Promoting Walking Among Older Adults Through Affective Communication and Step-Monitoring (NOSTEP)

9 giugno 2026 aggiornato da: Patrizia Catellani, Catholic University, Italy

Self-Continuity Messages and Step-Monitoring to Promote Walking Among Older Adults: Protocol of a 4-Arm Randomised Controlled Trial

Physical inactivity increases substantially after age 60 and represents a major public health challenge in older adults, as it is linked to increased risk of functional and cognitive decline and aging problems. Walking is one of the most accessible and recommended forms of light-to-moderate physical activity for this population. However, promoting sustained engagement in walking remains difficult, as traditional informational approaches often fail to activate personally meaningful motivations.

This study tests whether persuasive affective messages can promote walking by leveraging self-continuity, meaning the use of autobiographical memory to maintain the sense of being the same person across time and contexts, connecting the past, present, and future self. Self-continuity is associated with psychological resources such as self-esteem, self-efficacy, and a sense of meaning in life. The affective mechanism that sustains self-continuity is nostalgia: both promote emotional and behavioral regulation and support goal achievement. Building on this framework, the present trial examines whether activating feelings of self-continuity and positive nostalgic memories can strengthen older adults' motivation to engage in walking behavior.

In addition, the study investigates whether combining self-continuity messaging with a self-regulation strategy (daily step monitoring) enhances intervention effectiveness. Self-monitoring is a well-established behavioral technique that supports goal pursuit by increasing awareness and feedback.

Using a 4-arm randomised controlled factorial design, the study compares the effects of self-continuity messages, step-monitoring reminders, their combination, and an active control condition on walking behaviour and its psychological determinants.

A national sample of 1,000 Italian adults aged 65-74, recruited through a certified panel provider (Ipsos) and balanced for age, gender, and geographic region, will be randomly assigned to one of the four conditions. All participants will receive one message per day through a mobile application over a 14-day period. Participants in the step-monitoring conditions will also be asked to track and report their daily step count using a pedometer application. Behavioral, psychological, and process measures will be collected at baseline, post-intervention, and follow-up.

The study therefore aims to provide experimental evidence on the role of self-continuity as a motivational driver of health behaviour change, and to clarify whether combining affective and self-regulatory strategies enhances intervention effectiveness in older adults.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

1000

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Milan
      • Milan, Milan, Italia, 20123
        • Catholic University of the Sacred Heart (Milan)
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto più anziano

Accetta volontari sani

Descrizione

Inclusion Criteria:

  • Age between 65 and 74 years
  • Willingness and ability to install and use the mobile applications required for study participation
  • Sufficient proficiency in the Italian language to understand study materials and complete the questionnaires.

Exclusion Criteria:

- Physical disabilities or medical conditions that preclude engagement in light to moderate physical activity, specifically:

  1. medical advice or prescription prohibiting engagement in light to moderate physical activity, assessed via a close-ended screening question;
  2. positive screening on a study specific close-ended question assessing ability to perform physical activity;
  3. positive screening on the adapted revised Physical Activity Readiness Questionnaire (rPAR-Q), indicating that participant may be unsafe.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione fattoriale
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Altro: Control
Participants assigned to this arm will receive daily messages about the benefits of recommended daily water intake via the PsyMe app over 14 days.
All messages, delivered digitally via PsyMe, differ in content and do not include any walking-related prompts. The Day 1 introductory message presents a daily water-intake goal consistent with standard recommendations and informs participants that subsequent messages describe the benefits of adequate hydration. Participants will be encouraged to pursue the goal according to their individual capabilities. Messages delivered from Day 2 to Day 13 provide brief information about different beneficial effects of adequate water intake and link hydration to each outcome using counterfactual formulations (e.g., "If you drink the recommended amount of water today, you may support your energy levels and help prevent lapses in concentration"). Message openings vary and include exclamatory statements, memory prompts, or rhetorical questions. The Day 14 message concludes the intervention.
Sperimentale: Self-continuity messages
Participants assigned to this arm will receive daily messages via the PsyMe app over 14 days. These messages are designed to prompt recall of personally relevant past experiences and to promote walking behavior.
All messages, delivered digitally via PsyMe, differ in content. The Day 1 introductory message presents a daily walking goal consistent with WHO recommendations and informs participants that subsequent messages describe the benefits of walking. Participants will be encouraged to pursue the goal according to their individual capabilities. Messages delivered from Day 2 to Day 13 are designed to activate different positive nostalgic experiences related to walking and movement, including past memories, emotions, bodily sensations, personal values, and self-concepts. The messages link walking behaviour to such positive experiences using counterfactual formulations (e.g., "If you walk a little more today, you may reconnect with sensations your body knows well."). Message openings vary and include exclamatory statements, memory prompts, or rhetorical questions. The Day 14 message concludes the intervention.
Comparatore attivo: Step-monitoring
Participants assigned to this arm will receive daily reminders to monitor and record their step count through a step-tracking application via the PsyMe app over 14 days.
All messages, delivered digitally via PsyMe, differ in content. The Day 1 introductory message presents a daily walking goal consistent with WHO recommendations and informs participants that subsequent messages prompt them to monitor their daily step count. Participants will be encouraged to pursue the physical activity goal according to their individual capabilities. Messages delivered from Day 2 to Day 13 provide reminders to monitor step counts throughout the day using the pedometer app and to record the total number of daily steps in PsyMe at the end of the day (e.g., "During the day, monitor your step count using the pedometer app. This evening, record the total number of steps in the app."). The Day 14 message concludes the intervention.
Sperimentale: Self-continuity + Step-monitoring
Participants assigned to this arm will receive daily messages via the PsyMe app over 14 days. These messages combine prompts recalling relevant past experiences and promoting walking behavior with reminders to monitor and record their daily step count.
The messages, delivered digitally via PsyMe, are constructed by combining the exact texts used in the self-continuity and step-monitoring conditions. The Day 1 introductory message presents a daily walking goal consistent with WHO recommendations and informs participants that subsequent messages describe the benefits of walking and prompt them to monitor their daily step count. Participants will be encouraged to pursue the physical activity goal according to their individual capabilities. Messages delivered from Day 2 to Day 13: 1) activate different positive nostalgic experiences related to movement and link walking behaviour to such positive experiences using counterfactual formulations, 2) provide reminders to track steps throughout the day using the pedometer app and record daily totals in PsyMe. The Day 14 message concludes the intervention.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change from Baseline in Self-Reported Walking Frequency and Duration at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed by International Physical Activity Questionnaire - Short Version (IPAQ). Higher scores (mean daily time spent in walking activities, number of days per week with walking activity, and mean time spent in walking activities multiplied by the number of days per week with walking activity) indicate greater self-reported walking activity over the past week and in a usual week.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Reported Walking Intensity at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed by International Physical Activity Questionnaire - Short Version (IPAQ). Higher scores indicate greater self-reported walking intensity over the past week and in a usual week, with 3 ordinal response options: slow, moderate, and vigorous intensity.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Daily Step Count at 2-Week Post-Intervention as Measured Via Pedometer App
Lasso di tempo: Baseline and 2 weeks
Higher self-reported step counts indicate greater walking activity over the past week and in a usual week.
Baseline and 2 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change from Baseline in Attitude toward Walking at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Measured using an ad-hoc 7-point semantic differential scale assessing anticipated attitude toward walking in the next two weeks, across six bipolar adjective pairs. Higher scores are associated with more positive attitudes toward walking.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Intention to Walk at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Measured using an ad hoc 7-point Likert scale comprising 3 items and assessing intention to walk as much as possible over the next two weeks. Responses range from 1 (completely disagree) to 7 (completely agree), with higher values indicating stronger intention to walk.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Efficacy to Walk at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Measured using a 12-item scale adapted from the Self-efficacy to Regulate Exercise scale (Carfora et al., 2022) to assess confidence in being able to walk as much as possible over the next two weeks under a variety of challenging circumstances. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicating greater self-efficacy to walk.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Anticipated Positive Emotions Toward Walking at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Evaluated using an ad-hoc 6-item scale assessing anticipated positive emotions associated with walking as much as possible over the next two weeks. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicating stronger anticipated positive emotions toward walking.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Anticipated Negative Emotions Toward Walking at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Evaluated using an ad-hoc 6-item scale assessing anticipated negative emotions associated with not walking as much as possible over the next two weeks. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicating stronger anticipated negative emotions toward not walking.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Reported Daily Water Intake at 2-Week Post-Intervention
Lasso di tempo: Baseline and 2 weeks
Measured using an ad-hoc close-ended single-item measure assessing usual number of glasses of water consumed in an ordinary day.
Baseline and 2 weeks
Change from Baseline in Attitude toward Water Intake at 2-Week Post-Intervention
Lasso di tempo: Baseline and 2 weeks
Measured using an ad-hoc 7-point semantic differential scale assessing anticipated attitude toward drinking at least 2 liters of water per day over the next two weeks, across six bipolar adjective pairs. Higher scores are associated with more positive attitudes toward drinking water.
Baseline and 2 weeks
Change from Baseline in Intention to Drink Water at 2-Week Post-Intervention
Lasso di tempo: Baseline and 2 weeks
Measured using an ad hoc 7-point Likert scale comprising 3 items and assessing intention to drink at least 2 liters of water per day over the next two weeks. Responses range from 1 (completely disagree) to 7 (completely agree), with higher values indicating stronger intention to drink water.
Baseline and 2 weeks
Change from Baseline in Self-Reported Sedentary Behaviour Duration at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed by International Physical Activity Questionnaire - Short Version (IPAQ). Higher self-reported minutes spent in sedentary activities indicate greater sedentary behaviour in a usual week.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Reported Light Physical Activity Frequency and Duration at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Adapted from the International Physical Activity Questionnaire - Short Version (IPAQ), specifically for light physical activity. Higher scores (mean daily time spent in light physical activities, number of days per week with light physical activity, and mean daily time multiplied by the number of days per week with light physical activity) indicate greater self-reported light physical activity in a usual week.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Reported Moderate Physical Activity Frequency and Duration at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed by International Physical Activity Questionnaire - Short Version (IPAQ). Higher scores (mean daily time spent in moderate physical activities, number of days per week with moderate physical activity, and mean daily time multiplied by the number of days per week with moderate physical activity) indicate greater self-reported moderate physical activity in a usual week.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Reported Vigorous Physical Activity Frequency and Duration at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed by International Physical Activity Questionnaire - Short Version (IPAQ). Higher scores (mean daily time spent in vigorous physical activities, number of days per week with vigorous physical activity, and mean daily time multiplied by the number of days per week with vigorous physical activity) indicate greater self-reported vigorous physical activity in a usual week.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Pedometer Usage and Usage Frequency (Past Week) at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Measured using a study-specific single item with 5 ordinal response options. Higher scores indicate more frequent mean daily use of the pedometer app/device.
Baseline and 2 weeks and 4 weeks

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Change from Baseline in State Nostalgia at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed using a study-adapted 3-item scale based on Wildschut et al. (2006) to measure recent feelings of nostalgia. The scale asks participants to indicate their agreement with statements such as "During the past week, I have felt rather nostalgic." Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicate greater state nostalgia.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Self-Continuity at 2-Week Post-Intervention and 4-Week Follow-up
Lasso di tempo: Baseline and 2 weeks and 4 weeks
Assessed using a 4-item scale translated from the Self-Continuity Index (Sedikides et al., 2015) to measure perceived continuity and stability between past and present self. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicating greater self-continuity.
Baseline and 2 weeks and 4 weeks
Change from Baseline in Attitudes Toward Aging at 2-Week Post-Intervention
Lasso di tempo: Baseline and 2 weeks
Assessed using a study-adapted 4-item scale based on the Positive View of Aging subscale of the AgeCog scale of Ongoing Development (Wurm et al., 2013) to measure positive attitudes toward aging. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher values reflecting more positive attitudes toward aging.
Baseline and 2 weeks
Change from Baseline in Psychological Well-Being at 2-Week Post-Intervention
Lasso di tempo: Baseline and 2 weeks
Assessed using the Italian translation of the 5-item Short Warwick-Edinburgh Mental Well-Being Scale (Soraci et al., 2024) to measure psychological well-being over the past two weeks. T. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher values reflecting greater psychological well-being.
Baseline and 2 weeks
Change from Baseline in Temporal Comparison at 2-Week Post-Intervention
Lasso di tempo: Baseline and 2 weeks
Assessed using a 11-item scale translated from the Measure of Temporal Comparison Orientation (Namikawa, 2011) to assess how frequently and intensely a person engages in temporal comparisons. Responses are given on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicating greater temporal comparison proneness.
Baseline and 2 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Collaboratori

Investigatori

  • Investigatore principale: Patrizia Catellani, Social Psychology, Catholic University, Italy

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 giugno 2026

Completamento primario (Stimato)

1 agosto 2026

Completamento dello studio (Stimato)

1 agosto 2026

Date di iscrizione allo studio

Primo inviato

30 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

30 aprile 2026

Primo Inserito (Effettivo)

6 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

11 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 6069838_48_26

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Periodo di condivisione IPD

They will be made available before

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi